These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Hellstern P, Halbmayer WM, Köhler M, Seitz R, Müller-Berghaus G. Thromb Res; 1999 Aug 15; 95(4 Suppl 1):S3-6. PubMed ID: 10499902 [No Abstract] [Full Text] [Related]
7. Thrombogenic materials in prothrombin complex concentrates. Blatt PM, Lundblad RL, Kingdon HS, McLean G, Roberts HR. Ann Intern Med; 1974 Dec 15; 81(6):766-70. PubMed ID: 4433081 [No Abstract] [Full Text] [Related]
8. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency. Hellstern P. Thromb Res; 1999 Aug 15; 95(4 Suppl 1):S7-12. PubMed ID: 10499903 [Abstract] [Full Text] [Related]
10. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Köhler M, Hellstern P, Lechler E, Uberfuhr P, Müller-Berghaus G. Thromb Haemost; 1998 Sep 15; 80(3):399-402. PubMed ID: 9759617 [Abstract] [Full Text] [Related]
12. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. Zivelin A, Rao LV, Rapaport SI. J Clin Invest; 1993 Nov 15; 92(5):2131-40. PubMed ID: 8227329 [Abstract] [Full Text] [Related]
15. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Girolami A, Scandellari R, Scapin M, Vettore S. Vitam Horm; 2008 Nov 15; 78():281-374. PubMed ID: 18374200 [Abstract] [Full Text] [Related]
16. Letter: Prothrombin-complex concentrates in liver disease. Lancet; 1975 Aug 16; 2(7929):328. PubMed ID: 50541 [No Abstract] [Full Text] [Related]